Nierziekte

PC-AKI na EVAR bij chronische nierziekte niet gekoppeld aan meer sterfte of dialyse

Een retrospectieve single-center studie onderzocht 164 patiënten met chronische nierziekte die een electieve EVAR ondergingen. Bij 10,4% trad post-contrast acute kidney injury (PC-AKI) op; hoewel de serumcreatinine in deze groep tijdelijk hoger bleef, daalde deze na 12 maanden significant en waren er geen verschillen in dialysestart (5,9% versus 0,7%; p=0,197) of algehele overleving (29,4% versus 23,8%; p=0,565). Het contrastvolume was geen onafhankelijke voorspeller van PC-AKI, terwijl een lagere preoperatieve eGFR dat wel was. Deze bevindingen suggereren dat contrastgebruik bij EVAR niet onnodig beperkt hoeft te worden uit angst voor nierfunctieverlies, mits het gebruik doordacht blijft.

Abstract (original)

BACKGROUND: Post-contrast acute kidney injury (PC-AKI) has been regarded as a serious complication after contrast administration, particularly in patients with chronic kidney disease (CKD). However, the prognostic significance of PC-AKI following endovascular aortic repair (EVAR) remains controversial due to heterogeneity in previous study populations. This study evaluated the association between PC-AKI and longitudinal changes in postoperative renal function and mortality in a well-defined CKD cohort undergoing EVAR. METHODS: We conducted a single-center retrospective study of patients with CKD undergoing elective, primary, and non-complex infrarenal EVAR. Patients were classified according to the presence or absence of PC-AKI. Longitudinal changes in serum creatinine after EVAR, dialysis initiation, all-cause mortality, and the association between contrast volume and PC-AKI were evaluated. RESULTS: Among 479 EVAR procedures, 164 patients with CKD were included, of whom 17 (10.4%) developed PC-AKI. The linear mixed-effects model showed a significant group-by-time interaction (P < .001). Serum creatinine remained significantly higher in the PC-AKI group than in the non-PC-AKI group at all postoperative time points. However, in the PC-AKI group, model-adjusted mean serum creatinine decreased significantly from 1.75 mg/dL in the postoperative period to 1.46 mg/dL at 12 months with an estimated change of -0.29 mg/dL (95% CI, -0.50 to -0.09; P = .003). No significant differences were observed in dialysis initiation (5.9% vs 0.7%; P = .197) or all-cause mortality (29.4% vs 23.8%; P = .565). Kaplan-Meier analysis showed no significant difference in overall survival between the groups (log-rank P = .246). In the multivariable analysis, contrast volume was not independently associated with PC-AKI (odds ratio [OR], 1.00; 95% CI, 0.98-1.01; P = .845), whereas lower preoperative estimated glomerular filtration rate remained significantly associated with PC-AKI (OR, 1.06 per 1 mL/min/1.73 m2 decrease; 95% CI, 1.01-1.12; P = .018). CONCLUSION: In this study, PC-AKI may not necessarily be associated with adverse subsequent renal or survival outcomes. In addition, underlying renal vulnerability may be more closely associated with the development of PC-AKI than contrast volume alone. While PC-AKI should not be disregarded, judicious contrast use to ensure appropriate assessment may be reasonable even in patients with CKD.Clinical ImpactPost-contrast acute kidney injury (PC-AKI) occurred in approximately 10% of patients with chronic kidney disease (CKD) undergoing elective, primary, non-complex infrarenal endovascular aortic repair (EVAR). Although serum creatinine remained higher in patients with PC-AKI at all postoperative time points, it decreased significantly from the postoperative period to 12 months. No significant differences were observed in dialysis initiation or overall survival between the groups. In addition, contrast volume was not independently associated with PC-AKI, whereas lower preoperative estimated glomerular filtration rate was. These findings suggest that contrast use should not be excessively restricted solely because of concerns regarding PC-AKI, and that judicious contrast use to ensure appropriate assessment may be reasonable even in patients with CKD.

Dit artikel is een samenvatting van een publicatie in Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists. Voor het volledige artikel, alle details en referenties verwijzen wij u naar de oorspronkelijke bron.

Lees het volledige artikel

DOI: 10.1177/15266028261494993

Wilt u op de hoogte blijven?

Gratis: de maandelijkse nieuwsbrief met het nieuwsoverzicht, en de site afgestemd op uw vakgebied.

Schrijf u nu in